Chairs: M.P. Amato (Florence, IT); T. Kümpfel (Munich, DE)

08:55 - 09:10 – The maternal perspective – when to stop/resume treatment and risks for

Progression – E. Portaccio (Florence, IT)

09:10 - 09:25 – The fetal/child perspective – risks related drug exposure of the child,

breastfeeding and when to reassume medication –  K. Hellwig (Bochum, DE)

09:25 - 09:40 – Patient awareness about family planning represents a major knowledge

gap in multiple sclerosis – M. D'Hooghe (Melsbroek, BE)

11 de setembro | 09:00 – 10:15| Hall E

Young Scientific Investigators' Session

Young Scientific Investigators' Session 1 – Biomarkers

Chairs: R. Diem (Heidelberg, DE); C. Teunissen (Amsterdam, NL)

09:00 - 09:15 – Serum neurofilament light chain levels are increased within three months

of new gadolinium enhancing lesions in multiple sclerosis – M. Rosso (Brookline, US)

09:15 - 09:30 – Serum neurofilament light chain is associated with MS outcomes and

comorbidity in a large population of people with multiple sclerosis – K. Fitzgerald (Baltimore, US)

09:30 - 09:45 – Neurofilament light chains in serum in biopsied multiple sclerosis

Patients – A.-S. Beutler (Göttingen, DE);

09:45 - 10:00 – The extent and distribution of fibrinogen deposition in progressive MS

correlate with meningeal and choroid plexus inflammation – A. Poli (Verona, IT);

10:00 - 10:15 – Polygenic risk for multiple sclerosis and multi-modal brain imaging

among 8-12 year old children in the general population – C.L. de Mol (Rotterdam, NL)